| Literature DB >> 30841421 |
Tâmara Coimbra Diniz1, Raimundo Gonçalves de Oliveira Júnior2, Maria Alice Miranda Bezerra Medeiros1, Mariana Gama E Silva2, Roxana Braga de Andrade Teles1, Paula Dos Passos Menezes3, Bruna Maria Hipólito de Sousa3, Luiza Abrahão Frank4, Adriano Antunes de Souza Araújo3, Mairim Russo Serafini3, Sílvia Stanisçuaski Guterres4, Carlos Eduardo Pereira Nunes5, Marcos José Salvador5, Jackson Roberto Guedes da Silva Almeida6.
Abstract
Annona vepretorum is an endemic species of the Caatinga biome, known in Northeastern Brazil as "araticum" and/or "pinha da Caatinga". In the present study it was evaluated the neuropharmacological potential of the essential oil obtained from the leaves of Annona vepretorum, as well as of the inclusion complexes of oil obtained with cyclodextrin. Thus, were used neuropharmacological tests already consolidated in the literature like open-field, elevated plus maze, rota-rod, tail suspension test, thiopental-induced sleep test, among others. The acute treatment of essential oil (EO) has anxiolytic, sedative, antiepileptic and antidepressant effects. The anxiolytic and anticonvulsant effects seems to be related to the GABAergic system, probably in the receptor subtypes that mediate the effects of the benzodiazepines, to generate anxiolytic activity. The sedative effect seems to be involved with other signaling pathways. The antidepressant effect of EO seems to be related to its action on serotonergic receptors. It was verified that some behavioral parameters were improved with the oil complexed with β-cyclodextrin, but this effect was not uniform for all the doses and tests used. Further studies are needed in order to use other options for drug delivery systems. Thus, the essential oil of Annona vepretorum is a promising agent with neurobiological activity and a potential target for drug discovery, since the natural products such as medicinal plants have been a source of new therapeutic proposals.Entities:
Keywords: Annona vepretorum; Anticonvulsant; Antidepressant; Anxiolytic; GABAergic
Mesh:
Substances:
Year: 2019 PMID: 30841421 DOI: 10.1016/j.biopha.2018.12.114
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529